Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16539)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2015 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aizawa Y, Seki N, Nagano T, Abe H. Chronic hepatitis C virus infection and lipoprotein metabolism. World J Gastroenterol 2015; 21(36): 10299-10313 [PMID: 26420957 DOI: 10.3748/wjg.v21.i36.10299] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i36/10299.htm |
| Number | Citing Articles |
| 1 |
Emilie Crouchet, Thomas F. Baumert, Catherine Schuster. Hepatitis C virus–apolipoprotein interactions: molecular mechanisms and clinical impact. Expert Review of Proteomics 2017; 14(7): 593 doi: 10.1080/14789450.2017.1344102
|
| 2 |
Joana Rita Carvalho, José Velosa, Fátima Serejo. Lipids, glucose and iron metabolic alterations in chronic hepatitis C after viral eradication – comparison of the new direct-acting antiviral agents with the old regimens. Scandinavian Journal of Gastroenterology 2018; 53(7): 857 doi: 10.1080/00365521.2018.1473486
|
| 3 |
Takeshi Chida, Kazuhito Kawata, Kazuyoshi Ohta, Erika Matsunaga, Jun Ito, Shin Shimoyama, Satoru Yamazaki, Hidenao Noritake, Tetsuro Suzuki, Takafumi Suda, Yoshimasa Kobayashi. Rapid Changes in Serum Lipid Profiles during Combination Therapy with Daclatasvir and Asunaprevir in Patients Infected with Hepatitis C Virus Genotype 1b. Gut and Liver 2018; 12(2): 201 doi: 10.5009/gnl17179
|
| 4 |
Laura Pellegrini, Anna Albecka, Donna L. Mallery, Max J. Kellner, David Paul, Andrew P. Carter, Leo C. James, Madeline A. Lancaster. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell 2020; 27(6): 951 doi: 10.1016/j.stem.2020.10.001
|
| 5 |
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
|
| 6 |
Lucas T. Jennelle, Tshifhiwa Magoro, Angelina R. Angelucci, Aditya Dandekar, Young S. Hahn. Hepatitis C Virus Alters Macrophage Cholesterol Metabolism Through Interaction with Scavenger Receptors. Viral Immunology 2022; 35(3): 223 doi: 10.1089/vim.2021.0101
|
| 7 |
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Takeshi Matsui, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12970
|
| 8 |
Sergio Ferra-Murcia, Antonio Ramón Collado-Romacho, Bruno José Nievas-Soriano, Fernando Reche-Lorite, Tesifón Parrón-Carreño. Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-Infection. Journal of Clinical Medicine 2022; 11(9): 2639 doi: 10.3390/jcm11092639
|
| 9 |
ARZU ALTUNÇEKİÇ YILDIRIM, Selma Cırrık, Yeliz Çetinkol, Mustafa Kerem Çalgın, Tevfik Noyan. Are serum GRP78 levels significant in chronic hepatitis C patients? A case-control study. Journal of Surgery and Medicine 2019; doi: 10.28982/josam.595537
|
| 10 |
Yunli Wu, Lan Ren, Chenglei Mao, Zhiqing Shen, Wenyu Zhu, Zhijun Su, Xinjian Lin, Xu Lin, Jae U. Jung. Small hepatitis B virus surface antigen (SHBs) induces dyslipidemia by suppressing apolipoprotein-AII expression through ER stress-mediated modulation of HNF4α and C/EBPγ. Journal of Virology 2024; 98(11) doi: 10.1128/jvi.01239-24
|
| 11 |
Srikanta Dash, Srinivas Chava, Yucel Aydin, Partha Chandra, Pauline Ferraris, Weina Chen, Luis Balart, Tong Wu, Robert Garry. Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response. Viruses 2016; 8(5): 150 doi: 10.3390/v8050150
|
| 12 |
Gilmar de Souza Lacerda, Thalia Medeiros, Natalia Fonseca do Rosário, Regina Helena Saramago Peralta, Mauro Jorge Cabral-Castro, Eliane Bordalo Cathalá Esberard, Thaís Guaraná de Andrade, Analúcia Rampazzo Xavier, Andrea Alice Silva. Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment. Clinical Biochemistry 2018; 60: 17 doi: 10.1016/j.clinbiochem.2018.07.007
|
| 13 |
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017). PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
|
| 14 |
Shailaja Mallya, Raghuvir R.S. Pissurlenkar. In-silico Investigations for the Identification of Novel Inhibitors Targeting Hepatitis C Virus RNA-dependent RNA Polymerase. Medicinal Chemistry 2024; 20(1): 52 doi: 10.2174/0115734064255683230919071808
|
| 15 |
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
|
| 16 |
Daisuke Morihara, Yi‐Ling Ko, Kumiko Shibata, Ryo Yamauchi, Hiromi Fukuda, Naoaki Tsuchiya, Atsushi Fukunaga, Hideo Kunimoto, Hideyuki Iwashita, Kazuhide Takata, Takashi Tanaka, Kunitoshi Sakurai, Shinjiro Inomata, Keiji Yokoyama, Shinya Nishizawa, Yasuaki Takeyama, Makoto Irie, Satoshi Shakado, Tetsuro Sohda, Shotaro Sakisaka. IL28B gene polymorphism is correlated with changes in low‐density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct‐acting antiviral treatment. Journal of Gastroenterology and Hepatology 2019; 34(11): 2019 doi: 10.1111/jgh.14741
|
| 17 |
Jorge Quarleri, M Victoria Delpino. Editorial: Metabolomics in chronic hepatitis C: Decoding fibrosis grading and underlying pathways. World Journal of Hepatology 2023; 15(11): 1170-1173 doi: 10.4254/wjh.v15.i11.1170
Abstract(411) |
Core Tip(358) |
Full Article(HTML)(903)
|
Full Article with Cover (PDF)-1152K(70)
|
Full Article (Word)-109K(22)
|
Audio-178K(4)
|
Peer-Review Report-218K(44)
|
Answering Reviewers-76K(41)
|
Full Article (PDF)-355K(79)
|
Full Article (XML)-45K(43)
|
Times Cited (0)
|
Total Visits (3334)
|
Open
|
| 18 |
Chengliang Zhu, Guosheng Gao, Hui Song, Fengxia Xu, Kailang Wu, Xinghui Liu. Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene. Lipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0340-2
|
| 19 |
Florian Wrensch, Emilie Crouchet, Gaetan Ligat, Mirjam B. Zeisel, Zhen-Yong Keck, Steven K. H. Foung, Catherine Schuster, Thomas F. Baumert. Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01436
|
| 20 |
Jihong Lian, Randal Nelson, Richard Lehner. Carboxylesterases in lipid metabolism: from mouse to human. Protein & Cell 2018; 9(2): 178 doi: 10.1007/s13238-017-0437-z
|
| 21 |
Riccardo Nevola, Luca Rinaldi, Letizia Zeni, Ferdinando C Sasso, Pia C Pafundi, Barbara Guerrera, Aldo Marrone, Mauro Giordano, Luigi E Adinolfi. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct‐acting antivirals. JGH Open 2020; 4(4): 713 doi: 10.1002/jgh3.12324
|
| 22 |
Rie Harada, Masako Kimura, Yasushi Sato, Tatsuya Taniguchi, Tetsu Tomonari, Takahiro Tanaka, Hironori Tanaka, Naoki Muguruma, Hirohiko Shinomiya, Hirohito Honda, Issei Imoto, Masahiro Sogabe, Toshiya Okahisa, Tetsuji Takayama. APOB codon 4311 polymorphism is associated with hepatitis C virus infection through altered lipid metabolism. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0747-5
|
| 23 |
Ruirui Feng, Xiaozhong Guo, Yun Kou, Xiangbo Xu, Cen Hong, Wenwen Zhang, Yang An, Cyriac Abby Philips, Andrea Mancuso, Xingshun Qi. Association of lipid profile with decompensation, liver dysfunction, and mortality in patients with liver cirrhosis. Postgraduate Medicine 2021; 133(6): 626 doi: 10.1080/00325481.2021.1930560
|
| 24 |
Marwa Ahmed Mohamed, Essam M. Bayoumy, Mostafa Mohamed Swailam, Ahmed Samir Allam. Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00218-8
|
| 25 |
M. Sidorkiewicz, M. Grek, B. Jozwiak, A. Krol, A. Piekarska. The impact of chronic hepatitis C infection on cholesterol metabolism in PBMCs is associated with microRNA-146a expression. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(4): 697 doi: 10.1007/s10096-016-2851-1
|
| 26 |
Maheswata Moharana, Subrat Kumar Pattanayak, Fahmida Khan. Identification of phytochemicals from Eclipta alba and assess their potentiality against Hepatitis C virus envelope glycoprotein: virtual screening, docking, and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics 2022; : 1 doi: 10.1080/07391102.2022.2085804
|
| 27 |
Kunitada Shimotohno. HCV Assembly and Egress via Modifications in Host Lipid Metabolic Systems. Cold Spring Harbor Perspectives in Medicine 2021; 11(1): a036814 doi: 10.1101/cshperspect.a036814
|
| 28 |
Rui Dong, Hong Xue, Lin Chen, Wenjuan Jin, Zhenghan Luo, Chao Shen, Lili Huang, Jianguo Shao, Jie Wang. Associations of Lipid Profiles With the Onset of HEV‐Related Acute Liver Failure: A Multicenter Cohort Study. Journal of Medical Virology 2024; 96(11) doi: 10.1002/jmv.70033
|
| 29 |
Annalisa Cespiati, Inês Coelho Rodrigues, Inês Santos, Sara Policarpo, Sofia Carvalhana, Anna Ludovica Fracanzani, Helena Cortez‐Pinto. Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review. Liver International 2024; 44(5): 1075 doi: 10.1111/liv.15876
|
| 30 |
Daisuke Endo, Kenichi Satoh, Noritomo Shimada, Atsushi Hokari, Yoshio Aizawa. Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b. World Journal of Gastroenterology 2017; 23(13): 2355-2364 doi: 10.3748/wjg.v23.i13.2355
|
| 31 |
Sin Man Lam, Xun Huang, Guanghou Shui. Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses. Trends in Endocrinology & Metabolism 2022; 33(8): 554 doi: 10.1016/j.tem.2022.04.011
|
| 32 |
Ashraf O. Abdelaziz, Hend I. Shousha, Ebada M. Said, Zeinab A. Soliman, Ahmed A. Shehata, Mohamed M. Nabil, Ahmed H. Abdelmaksoud, Tamer M. Elbaz, Fatma M. Abdelsalam. Evaluation of liver steatosis, measured by controlled attenuation parameter, in patients with hepatitis C-induced advanced liver fibrosis and hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2018; 30(11): 1384 doi: 10.1097/MEG.0000000000001196
|
| 33 |
Ahmed Samir Allam, Mohamed Lotfy Abd Elmeged, Sameh Mohamed Ghaly, Osama Ashraf Ahmed, Gina Gamal Naguib, Ahmed Samir Abohalima. Impact of direct-acting antiviral therapy on metabolic profiles and adiponectin serum level in different categories of patients with chronic hepatitis C infection. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00194-z
|
| 34 |
Mohammed A. Sarhan, Mohamed S. Abdel-Hakeem, Andrew L. Mason, D. Lorne Tyrrell, Michael Houghton. Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-02648-6
|
| 35 |
Leonor Jacobo-Albavera, Mayra Domínguez-Pérez, Diana Jhoseline Medina-Leyte, Antonia González-Garrido, Teresa Villarreal-Molina. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease. International Journal of Molecular Sciences 2021; 22(4): 1593 doi: 10.3390/ijms22041593
|
| 36 |
Eric Piver, Audrey Boyer, Julien Gaillard, Anne Bull, Elodie Beaumont, Philippe Roingeard, Jean-Christophe Meunier. Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture. Gut 2017; 66(8): 1487 doi: 10.1136/gutjnl-2016-311726
|
| 37 |
Srikanta Dash, Yucel Aydin, Christopher M. Stephens. Viral Polymerases. 2019; : 211 doi: 10.1016/B978-0-12-815422-9.00008-5
|
| 38 |
Yuyan Gui, Nan Chu, Xuemin Qiu, Wei Tang, Hans-Jürgen Gober, Dajin Li, Ling Wang. 17-β-estradiol up-regulates apolipoprotein genes expression during osteoblast differentiation <i>in vitro </i>. BioScience Trends 2016; 10(2): 140 doi: 10.5582/bst.2016.01007
|
| 39 |
Kylie Su Mei Yong, Zhisheng Her, Qingfeng Chen. Humanized Mouse Models for the Study of Hepatitis C and Host Interactions. Cells 2019; 8(6): 604 doi: 10.3390/cells8060604
|
| 40 |
Alexia de Cassia Oliveira Zanelatto, Gilmar de Souza Lacerda, Camila de Melo Accardo, Natalia Fonseca do Rosário, Andréa Alice da Silva, Guacyara Motta, Ivarne Luis dos Santos Tersariol, Analucia Rampazzo Xavier. Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection. Microorganisms 2022; 10(9): 1769 doi: 10.3390/microorganisms10091769
|
| 41 |
Amr Ali Hemeda, Amal Ahmad Mohamed, Ramy Karam Aziz, Mohamed S. Abdel-Hakeem, Marwa Ali-Tammam. Impact of IL10, MTP, SOD2, and APOE Gene Polymorphisms on the Severity of Liver Fibrosis Induced by HCV Genotype 4. Viruses 2021; 13(4): 714 doi: 10.3390/v13040714
|
| 42 |
Chuan Qin, Yalan Lu, Lin Bai, Kewei Wang, Bing Su. The molecular regulation of autophagy in antimicrobial immunity. Journal of Molecular Cell Biology 2022; 14(4) doi: 10.1093/jmcb/mjac015
|
| 43 |
Gustavo Henrique De Puy e SOUZA, Luciana Diniz SILVA, Diego Alves VIEIRA, Gifone Aguiar ROCHA, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C. Arquivos de Gastroenterologia 2023; 60(3): 287 doi: 10.1590/s0004-2803.230302023-03
|
| 44 |
Stefan Mauss, Florian Berger, Malte H Wehmeyer, Patrick Ingiliz, Dietrich Hueppe, Thomas Lutz, Karl G Simon, Knud Schewe, Juergen K Rockstroh, Axel Baumgarten, Stefan Christensen. Effect of Antiviral Therapy for HCV on Lipid Levels. Antiviral Therapy 2017; 22(1): 81 doi: 10.3851/IMP3094
|
| 45 |
Mahmoud Abdo, Ahmed Rabiee, Zeinab Abdellatif, Shereen Abdel Alem, Ahmed Moustafa. Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir. European Journal of Gastroenterology & Hepatology 2021; 33(12): 1588 doi: 10.1097/MEG.0000000000001903
|
| 46 |
Huixin Hou, Yaoting Ji, Yu Pan, Ling Wang, Yong Liang. Persistent organic pollutants and metabolic diseases: From the perspective of lipid droplets. Environmental Pollution 2024; 362: 124980 doi: 10.1016/j.envpol.2024.124980
|